Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers

FDA Guidance FDA CDRH/CBER 2024-08-01
Home/ Resources/ Voluntary Malfunction Summary Reporting (VMSR)…

Summary

Final Guidance
Post-Market Surveillance

This FDA guidance document provides recommendations and regulatory information for the medical device industry. It was issued by the Center for Devices and Radiological Health (CDRH) in collaboration with the Center for Biologics Evaluation and Research (CBER).

Document Details

  • Issuing Authority: FDA CDRH/CBER
  • Status: Final
  • Topic Area: Post-Market Surveillance
  • Date: 2024-08-01

Access the Full Document

View on FDA.gov →

Source: U.S. Food and Drug Administration (FDA). This content is provided for informational purposes. Always refer to the official FDA document for the most current version.

Document Details

Document IDFDA-CDRH-VOLUNTARY-MALFUNCTION-SUMMARY-REPORTING-VMSR-PROGR
TypeFDA Guidance
AuthorityFDA CDRH/CBER
Publication Date2024-08-01

Download Document

Download PDF

Categories

Quick Info

TypeFDA Guidance
Published ByFDA CDRH/CBER
Date2024-08-01

Regulatory Support

Need help understanding this guidance document?

Contact Us
Scroll to Top